Management of LDL-C to reduce cardiovascular risk in nondialysis CKD patients

Statin for secondary prevention if

A patient has established atherosclerotic CVD (prior history of coronary, cerebrovascular, or peripheral arterial disease)

Statin for primary prevention if

Option A*:

All patients with GFR <60 mL/min

Patients with CKD and GFR ≥60 mL/min and age ≥50 years

Patients with CKD and GFR ≥60mL/min and other CVD risk factors (eg, diabetes, hypertension, smoking, low HDL-C, high Lp(a), etc)

Option B*:

Statin if predicted 10-year absolute risk of having a major CVD event is 7.5 to 10% or higher

Statin might be offered if risk is between 5 and 7.5%

No statin if risk is below 5%

LDL-C: low-density lipoprotein cholesterol; CKD: chronic kidney disease; CVD: cardiovascular disease; GFR: glomerular filtration rate; HDL-C: high-density lipoprotein cholesterol; Lp(a): lipoprotein(a).
* Option A and Option B reflect differing opinions among UpToDate authors and editors about criteria for initiating statin therapy in patients with nondialysis CKD.

Courtesy of Florian Kronenberg, MD.

Graphic 118900 Version 1.0

خرید پکیج

Management of LDL-C to reduce cardiovascular risk in nondialysis CKD patients